HOME >> MEDICINE >> NEWS
Infection puts extremely low birth weight infants at risk for developmental delays

Extremely low birth weight infants--the tiniest category of premature infants--are much more likely to experience developmental impairments if they acquire an infection during the newborn period, according to a study by the Neonatal Research Network of the National Institute of Child Health and Human Development, one of the National Institutes of Health. The developmental impairments were seen regardless of the type of infection--whether it occurred in the brain, blood or intestines.

The study was conducted by Barbara J. Stoll, M.D., of the Emory University School of Medicine in Atlanta, Georgia and her colleague. Appearing in the November 17 Journal of the American Medical Association, the study reported that 65 percent of a group of extremely low birth weight infants had developed at least one infection during their hospitalizations after birth. These infants were more likely to have an impairment than were infants who had not developed an infection.

"This study shows us that successfully treating an extremely low birth weight infant's infection does not automatically ensure that the infant will do well," said NICHD Director Duane Alexander, M.D. "Parents and health care workers need to monitor these children carefully as they grow, and be ready to provide them with developmental and educational services, if necessary."

According to the U.S. Centers for Disease Control and Prevention, there were 60,326 very low birth weight infants born in 2002, or 1.46 percent of the 4,021,726 total births for that year. Infants are classified as low birth weight if they are born weighing less than 2500 grams (about 5.5 pounds) and very low birth weight if they weigh less than1500 grams (about3.3 pounds). In the current study, the researchers analyzed the records of extremely low birth weight (ELBW) infants--those weighing less than 1000grams, or 2.2 pounds. Yearly statistics are not compiled on ELBW infants. Study co-author Rosemary Higgins, M.D.,
'"/>

Contact: Robert Bock or Marianne Glass Miller
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development
16-Nov-2004


Page: 1 2 3

Related medicine news :

1. Infection in breast implants
2. No advantage of combination drug therapy for chronic hepatitis B Infection
3. Infection in ELBW infants linked with poor neurodevelopmental, growth outcomes
4. Infections in low-birth-weight infants are associated with impaired neurodevelopment and growth
5. Infection, not lack of oxygen, plays larger role in premature infant brain injury
6. Infections linked to mental decline in elderly
7. Infection with toxoplasmososis increases the risk of being involved in a road traffic accident
8. Holding Policy Is Cost-Effective Way To Further Protect Blood Plasma Supply From HIV And Other Infections
9. Silent HIV Infection Lasts A Lifetime
10. New Contact Lens Material Could Lessen Risk Of Eye Infection
11. Study Offers Hope For Immune Reconstitution After HIV Infection

Post Your Comments:
(Date:5/21/2013)... (PRWEB) May 21, 2013 DISCcert has ... showing how to use 17 DISC applications at the ... a natural progression. , The July 25 & 26th ... top 17 ways of applying DISC. The time-tested, proven ... graduates. The user-friendly DISC training materials ; ...
(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...
(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...
(Date:5/21/2013)... Angeles, CA (PRWEB) May 21, 2013 According ... “Time to Rethink the Use of Botox,” Botox ... world since their approval in 2002 (Go to goo.gl/8iYbD). Although ... become quite popular with men. The injection makes facial wrinkles ... single Botox injection last for about three months. This means ...
Breaking Medicine News(10 mins):Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:Glaucoma drug can cause droopy eyelids 2Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2
(Date:5/21/2013)... , May 21, 2013  Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...
(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES   ... study is to offer synopsis of the ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19
Cached News: